REQUEST A DEMO
Total
USD $0.00
Search more companies

Fomat Medical Research S.A. (Ecuador)

Main Activities: General Medical and Surgical Hospitals
Full name: Fomat Medical Research S.A. Profile Updated: February 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Fomat Medical Research specializes in conducting clinical trials and providing tailored services to sponsors and CROs in the pharmaceutical industry. They have various sites throughout California and a diverse patient population, positioning them to help organizations in vaccine development.

Headquarters
Av. Miguel H. Alcivar, Torre a Bldg. , Floor 402
Guayaquil; Guayas;

Contact Details: Purchase the Fomat Medical Research S.A. report to view the information.

Website: http://www.fomatmedical.com

Basic Information
Total Employees:
Purchase the Fomat Medical Research S.A. report to view the information.
Registered Capital:
Purchase the Fomat Medical Research S.A. report to view the information.
Financial Auditors:
Purchase the Fomat Medical Research S.A. report to view the information.
Incorporation Date:
January 18, 2013
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
66%
Purchase this report to view the information.
34%
Company Performance
Financial values in the chart are available after Fomat Medical Research S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
7.95%
Total operating revenue
7.95%
Operating Profit/Loss (EBIT)
2.57%
EBITDA
-2.27%
Net Profit/Loss for the Period
48.9%
Total Assets
-5.22%
Total Equity
4.05%
Operating Profit Margin (ROS)
-0.03%
Net Profit Margin
0.01%
Return on Equity (ROE)
1.17%
Debt/Equity
-12.95%
Quick Ratio
0.28%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?